Regulations around mifepristone, a common drug used for medication abortion, make it difficult for miscarrying patients to access it. A new petition to the FDA asks for a label change to make it easier to obtain.
Jennifer Gerson
October 4, 2022
Over 40 medical and advocacy groups submitted a petition to the Food and Drug
Administration (FDA) asking for miscarriage management to be added as a use
case for mifepristone, a drug commonly used in medical abortions, and ease the
restrictions around who can prescribe it.
Groups including the American College of Obstetricians and Gynecologists
(ACOG), SisterReach, Physicians for Reproductive Health and the Expanding
Medication Abortion Access (EMAA) Project were behind the petition. The changes
they asked for Tuesday would make the drug easier to access for people
experiencing miscarriages as some doctors and pharmacies have become more
reluctant to distribute it after the end of Roe v. Wade.
Continued: https://19thnews.org/2022/10/mifepristone-miscarriage-label-change-fda-petition/